Eris Lifesciences Ltd (BOM:540596)
₹ 1353.8 11.3 (0.84%) Market Cap: 184.29 Bil Enterprise Value: 213.23 Bil PE Ratio: 52.93 PB Ratio: 6.65 GF Score: 93/100

Q1 2025 Eris Lifesciences Ltd Earnings Call Transcript

Aug 02, 2024 / 11:30AM GMT
Release Date Price: ₹1121.95 (+0.26%)
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY25 earnings conference call of Eris Lifesciences Limited. We have with us on the call today are Mr. Amit Bakshi, Chairman and Managing Director; Mr. V. Krishnakumar, Chief Operating Officer and Executive Director; Mr. Sachin Shah, Chief Financial Officer, and Ms. Kruti Raval, Head, Investor Relations.

(Operator Instructions) Please note this call is being recorded. I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company.

Thank you, and over to you. Sir.

Krishnakumar Vaidyanathan
Eris Lifesciences Ltd - Chief Operating Officer, Executive Director

Good evening, everybody, and welcome to our Quarter one, conference call. So before we dive into the details, it's probably useful to take a couple of minutes to articulate how we think about our business, how the business is structured. There's been a lot of change in the last few months. And that also gives you a sense of how this presentation is organized. So we have two business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot